Related Experiment Video
Updated: May 16, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Thrombosis in Hb Taybe [codons 38/39 (-ACC) (α1)]
Maja Bech Juul1, Hanne Vestergaard, Jesper Petersen
1Department of Haematology, Odense University Hospital, Odense, Denmark. majajuul@dadlnet.dk
This study details a rare case of compound heterozygosity for unstable hemoglobin (Hb) Taybe and an alpha-globin gene deletion, leading to hemolytic anemia, stroke, and priapism. The findings suggest a link between these genetic factors and thrombotic events.
Area of Science:
- Hematology
- Genetics
Background:
- Hemoglobin (Hb) variants can cause significant hematological disorders.
- Hb Taybe, an unstable Hb variant, results from a specific deletion in the α1-globin gene.
- Compound heterozygosity for globin gene mutations can lead to complex clinical presentations.
Observation:
- A Palestinian male presented with moderate hemolytic anemia since childhood.
- The patient had Hb Taybe and a 5 bp deletion at the splice donor site of the α2-globin gene (IVS-I).
- He developed priapism post-splenectomy and experienced a pontine infarction at age 28, with a co-existing prothrombin G20210A mutation.
Findings:
- This is the first reported case of compound heterozygosity for Hb Taybe and an α2-globin gene splice donor site deletion.
- Intravascular hemolysis, splenectomy, and the prothrombin G20210A mutation are hypothesized to contribute to the patient's thrombotic tendency.
- The combination of genetic factors and clinical history provides insight into complex thrombophilia.
Implications:
- This case highlights the importance of comprehensive genetic analysis in patients with unexplained thrombotic events and hemolytic anemia.
- Understanding rare Hb variants and their interactions is crucial for accurate diagnosis and management.
- Further research may elucidate the precise mechanisms linking these genetic mutations to thrombotic complications.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Multiple Allele Traits
Hepatitis

